- Home
- ASTL vs LRMR Comparison
ASTL vs LRMR Comparison
Compare ASTL & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASTL | LRMR |
|---|---|---|
| Founded | 1902 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 474.3M | 455.8M |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ASTL | LRMR |
|---|---|---|
| Price | $4.55 | $4.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $16.50 |
| AVG Volume (30 Days) | 1.0M | ★ 1.3M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.12% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $23.04 | $1,816.14 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.02 | $2.72 |
| 52 Week High | $5.90 | $6.42 |
Technical Indicators
Market Signals| Indicator | ASTL | LRMR |
|---|---|---|
| Relative Strength Index (RSI) | 58.61 | 63.14 |
| Support Level | $4.54 | $4.21 |
| Resistance Level | $4.78 | $5.35 |
| Average True Range (ATR) | 0.31 | 0.24 |
| MACD | 0.06 | 0.03 |
| Stochastic Oscillator | 93.33 | 99.34 |
Price Performance
Historical ComparisonAbout ASTL Algoma Steel Group Inc.
Algoma Steel Group Inc is a fully integrated steel producer of hot and cold rolled steel products, including coiled sheet and plate, strategically located. The firm operates in a single segment of basic steel production including sheets, plates, slabs, and freights. The company's revenue is generated from contracts to produce, ship, and deliver steel products Geographically it serves Canada, the United States, and the rest of the world, whilst driving key revenue from United States. The company generates the majority of its revenue from the sale of Steel sheets and strips.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.